查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1944487

全球心臟定位市场：按类型、适应症、最终用户、国家和地区划分－产业分析、市场规模、份额和预测（2025-2032年）

Cardiac Mapping Market, By Type, By Indication, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 331 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，心臟定位市场规模将达到 37.8912 亿美元，从 2025 年到 2032 年，复合年增长率将达到 7.5%。

心臟定位是一种先进的电生理技术，使医生能够追踪和研究心臟的电活动模式，并识别和治疗心律不整。此过程包括将导管电极插入心臟，并收集电活动数据，从而绘製出心臟内异常电脉衝传导的详细图谱。先进的心臟定位系统能够产生二维和三维电解剖图，使医生能够识别诱发心律不整的组织，并精确指导心导管电气烧灼术治疗，从而提高手术疗效和患者预后。心臟定位是治疗心房颤动、心房扑动和心室心搏过速的标准方法，也是现今微创心臟电生理手术的重要组成部分。

心臟定位市场动态

老化与心血管疾病（CVD）的增加

心臟定位市场正在扩张，主要受两大因素驱动：人口老化和心血管疾病盛行率上升。随着老龄化增长，心臟的结构和电生理变化使老年人更容易出现心律不整，例如心房颤动、心房扑动和心室心搏过速。高血压、糖尿病、肥胖和缺乏运动等因素的增加，正成为全球心血管疾病的危险因素，导致越来越多的患者出现心律不整，需要全面的诊断和治疗方案。随着医院和心臟护理中心寻求透过先进的心臟定位技术来提高诊断能力、治疗效果和患者健康水平，对电生理手术的需求日益增长，尤其是利用心臟定位系统的心导管电气烧灼术手术。

心臟定位市场：細項分析

按类型

预计到2024年，接触式心臟定位系统将占据最大的市场份额。这一增长主要归因于因心臟异常入院治疗的患者人数不断增加，从而推动了全球对先进心臟定位系统的需求。随着主要企业努力获得其心臟定位系统的核准，预计该细分市场将继续扩张。

心臟定位市场—区域分析

北美引领心臟标测产业。美国和加拿大凭藉心臟节律紊乱的高发病率、完善的心臟护理设施、现代化标测系统的全面应用以及众多大型医疗设备製造商的存在，在市场上占据市场领导地位，并显着促进该地区乃至全球心臟定位市场的成长。

目录

第一章心臟定位市场概览

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章心臟定位的关键市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章心臟定位市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章心臟定位市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章心臟定位市场概况

  • 心臟定位市场占有率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章心臟定位市场（依类型划分）

  • 概述
    • 细分市场占有率分析：按类型
    • 接触式心臟定位系统
    • 非接触式心臟定位系统

第八章 依适应症分類的心臟定位市场

  • 概述
    • 细分市场占有率分析：依指标
    • 心房颤动（心房颤动）
    • 房室折返性心搏过速（AVRT）
    • 房室结折返性心搏过速（AVNRT）
    • 心房扑动
    • 心室性心搏过速（VT）
    • 室性早搏（PVC）
    • 其他的

第九章心臟定位市场：依最终用户划分

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 专科诊所
    • 电生理检查室
    • 医院和门诊手术中心（ASC）
    • 学术和研究机构
    • 其他的

第十章 区域心臟定位市场

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十一章 主要供应商分析—心臟定位产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • GE HealthCare
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic plc
    • MicroPort Scientific Corporation
    • EP Solutions SA
    • Acutus Medical
    • CathRx Ltd
    • Biosense Webster（Johnson &Johnson）
    • Siemens Healthineers
    • BIOTRONIK SE &Co. KG
    • Philips Healthcare
    • Lepu Medical Technology
    • Topera（Acquired by Abbott）
    • Stereotaxis Inc.
    • Bardy Diagnostics
    • CARTO（part of Biosense Webster）
    • Imricor Medical Systems
    • CardioFocus Inc.
    • APN Health, LLC

第十二章：分析师视角360度分析

简介目录
Product Code: ANV6031

The Cardiac Mapping Market size was valued at US$3,789.12 Million in 2024, expanding at a CAGR of 7.5% from 2025 to 2032.

Cardiac mapping functions as an advanced electrophysiological method which enables doctors to track and study heart electrical patterns for the purpose of identifying and treating heart rhythm disorders. The process requires the insertion of catheter-based electrodes into the heart which they use to collect electrical data that produces detailed maps of abnormal electrical impulse propagation in the heart. Advanced cardiac mapping systems create two-dimensional and three-dimensional electro-anatomical maps which allow doctors to find arrhythmogenic tissue and direct catheter ablation treatments while enhancing their procedural effectiveness and patient results. Cardiac mapping functions as a standard method for treating atrial fibrillation and atrial flutter and ventricular tachycardia while serving as a vital component of current minimally invasive cardiac electrophysiology procedures.

Cardiac Mapping Market- Market Dynamics

Aging population and rising CVD burden

The cardiac mapping market experiences expansion because of two primary factors which include the increasing number of elderly people and the growing prevalence of cardiovascular diseases. The structural and electrical changes that occur in the heart because of aging make older adults more vulnerable to cardiac arrhythmias which include atrial fibrillation and atrial flutter and ventricular tachycardia. The global population experiences rising cardiovascular disease risk factors through increasing rates of hypertension and diabetes and obesity and lack of physical activity which results in more people developing rhythm disorders that need complete diagnostic and treatment solutions. The need for electrophysiology procedures is increasing especially for catheter ablation procedures which use cardiac mapping systems as hospitals and cardiac care centers seek to improve their diagnostic capabilities and procedure results and patient health through advanced cardiac mapping technologies.

Cardiac Mapping Market- Segmentation Analysis:

By Type

In 2024, the contact cardiac mapping systems segment holds the largest market share. The growth is due to increasing number of patient admissions for the treatment of heart abnormalities, which creates growing need for advanced cardiac mapping systems throughout the world. The segment will continue to expand because major companies now work to obtain approval for their cardiac mapping systems.

Cardiac Mapping Market- Geographical Insights

North America leads the industry. The United States and Canada exhibit market control because of their high occurrence of cardiac rhythm disorders and their established heart treatment facilities and their complete use of modern mapping systems and their presence of major medical equipment manufacturers. North America will keep its market leadership position through future years because of rising treatment numbers and continuous technological advancements and ongoing funding for electrophysiology development which will drive substantial growth in the cardiac mapping market throughout both regional and global markets.

Cardiac Mapping Market- Competitive Landscape:

The competitive landscape of the cardiac mapping market is led by a handful of large medtech firms that dominate through broad portfolios, global distribution, and heavy R&D investment-most notably Biosense Webster (Johnson & Johnson), Abbott, Boston Scientific, and Medtronic-while other established names (Philips, Siemens/GE partners, BIOTRONIK) and regional players (MicroPort, Lepu) fill out the field. The leading companies in the industry compete against each other by launching new mapping platforms and catheters which include 3D electro-anatomical systems and high-density/real-time mapping and integrated imaging and AI functionalities because these products create higher costs for customers who want to switch and they decrease the time products remain competitive in the market. A wave of smaller, fast-moving companies and startups (Acutus, Kardium, Biosig, Ablacon and others) develop niche advantages through their innovative sensor designs and signal-processing algorithms and affordable systems which drive established companies to develop new products and form partnerships and pursue targeted mergers and acquisitions.

Recent Developments:

In February 2025, Boston Scientific Corporation announced it has received CE mark for the navigation-enabled FARAWAVE(TM) NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) and for the new FARAVIEW(TM) Software. Both technologies will integrate and expand mapping option capabilities for cardiac ablation procedures using the FARAPULSE(TM) Pulsed Field Ablation (PFA) System, the most clinically proven PFA system for the treatment of AF, which has already benefited 200,000 patients globally. These technologies are compatible exclusively with the company's existing cardiac mapping technology and the company's latest offering, the OPAL HDx(TM) Mapping System.

In December 2025, Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt(TM) PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin commercial PFA cases in the United States and will continue its expansion of sites in the European Union following Volt CE Mark approval earlier this year.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC MAPPING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE HealthCare
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • EP Solutions SA
  • Acutus Medical
  • CathRx Ltd
  • Biosense Webster (Johnson & Johnson)
  • Siemens Healthineers
  • BIOTRONIK SE & Co. KG
  • Philips Healthcare
  • Lepu Medical Technology
  • Topera (Acquired by Abbott)
  • Stereotaxis Inc.
  • Bardy Diagnostics
  • CARTO (part of Biosense Webster)
  • Imricor Medical Systems
  • CardioFocus Inc.
  • APN Health, LLC

GLOBAL CARDIAC MAPPING MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Contact Cardiac Mapping Systems
  • Non-contact Cardiac Mapping Systems

GLOBAL CARDIAC MAPPING MARKET, BY INDICATION - MARKET ANALYSIS, 2019 - 2032

  • Atrial Fibrillation (AF)
  • Atrioventricular Reentrant Tachycardia (AVRT)
  • Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
  • Atrial Flutter
  • Ventricular Tachycardia (VT)
  • Premature Ventricular Contractions (PVCs)
  • Others

GLOBAL CARDIAC MAPPING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Specialty Clinics
  • Electrophysiology (EP) Labs
  • Hospitals and ASCs
  • Academic & Research Institutes
  • Others

GLOBAL CARDIAC MAPPING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cardiac Mapping Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cardiac Mapping Market Snippet by Type
    • 2.1.2. Cardiac Mapping Market Snippet by Indication
    • 2.1.3. Cardiac Mapping Market Snippet by End User
    • 2.1.4. Cardiac Mapping Market Snippet by Country
    • 2.1.5. Cardiac Mapping Market Snippet by Region
  • 2.2. Competitive Insights

3. Cardiac Mapping Key Market Trends

  • 3.1. Cardiac Mapping Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cardiac Mapping Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cardiac Mapping Market Opportunities
  • 3.4. Cardiac Mapping Market Future Trends

4. Cardiac Mapping Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cardiac Mapping Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cardiac Mapping Market Landscape

  • 6.1. Cardiac Mapping Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cardiac Mapping Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Contact Cardiac Mapping Systems
    • 7.1.3. Non-contact Cardiac Mapping Systems

8. Cardiac Mapping Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024&2032 (%)
    • 8.1.2. Atrial Fibrillation (AF)
    • 8.1.3. Atrioventricular Reentrant Tachycardia (AVRT)
    • 8.1.4. Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
    • 8.1.5. Atrial Flutter
    • 8.1.6. Ventricular Tachycardia (VT)
    • 8.1.7. Premature Ventricular Contractions (PVCs)
    • 8.1.8. Others

9. Cardiac Mapping Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 9.1.2. Specialty Clinics
    • 9.1.3. Electrophysiology (EP) Labs
    • 9.1.4. Hospitals and ASCs
    • 9.1.5. Academic & Research Institutes
    • 9.1.6. Others

10. Cardiac Mapping Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cardiac Mapping Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cardiac Mapping Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cardiac MappingKey Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cardiac Mapping Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cardiac MappingKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Cardiac Mapping Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. GE HealthCare
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Boston Scientific Corporation
    • 11.2.4. Medtronic plc
    • 11.2.5. MicroPort Scientific Corporation
    • 11.2.6. EP Solutions SA
    • 11.2.7. Acutus Medical
    • 11.2.8. CathRx Ltd
    • 11.2.9. Biosense Webster (Johnson & Johnson)
    • 11.2.10. Siemens Healthineers
    • 11.2.11. BIOTRONIK SE & Co. KG
    • 11.2.12. Philips Healthcare
    • 11.2.13. Lepu Medical Technology
    • 11.2.14. Topera (Acquired by Abbott)
    • 11.2.15. Stereotaxis Inc.
    • 11.2.16. Bardy Diagnostics
    • 11.2.17. CARTO (part of Biosense Webster)
    • 11.2.18. Imricor Medical Systems
    • 11.2.19. CardioFocus Inc.
    • 11.2.20. APN Health, LLC

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us